Home | Infections | Hepatitis


One in four hepatitis C patients denied initial approval for drug treatment

Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most ...

Expression of a single gene lets scientists easily grow hepatitis C virus in the lab

Worldwide, 185 million people have chronic hepatitis C. Since the late 1980s, when scientists discovered the virus that causes the infection, they ...

Urgent action needed on hepatitis

Across the world, viral hepatitis causes 1·44 million deaths every year – a figure comparable to deaths from conditions such as HIV/AIDS (1·46 million), tuberculosis (1·20 million) and malaria (1·17 million). ... Full story

Hepatitis B continues to be a global health problem

Study elucidates on the global and country-specific prevalence of chronic hepatitis B virus infection ... Full story

Penn Authors Urge Transplantation of Hepatitis C-Infected Kidneys in Some Non-Infected Patients

NEJM Perspective Points to Use of Hepatitis C-Positive Kidneys as One Solution to Kidney Shortage ... Full story

China's hepatitis crises

La Trobe study shows gaps in China's health system contributing to hepatitis epidemic. ... Full story

The new detection method for a key drug resistant hepatitis C virus mutation

A rapid, sensitive, and accurate method to detect drug resistant hepatitis C virus (HCV) mutants has been developed. Researchers at Hiroshima University established a system and evaluate the proportion of patients harboring this mutation prior to treatment. This new system for detecting mutant strains may provide important pre-treatment information valuable not only for treatment decisions but also for prediction of disease progression in HCV genotype 1b patients. ... Full story

New Hepatitis C Treatment Needs No Antiviral Boost

The drug approved to treat patients infected with the hepatitis C virus needs no help from other antivirals, according to a study released online this week in the journal Hepatology. ... Full story

Helping doctors predict what’s next for patients diagnosed with Hepatitis C

Patient risk model can help target costly HCV treatment to those with most urgent need ... Full story

Hepatitis C success based on strong research

The new hepatitis C drugs represent a genuine breakthrough in pharmaceutical research, and would not have been possible without the work done on the virus by Charles Rice at Rockefeller University. Dr Rice is now coming to Sweden to speak about hepatitis C for the annual Nicholson lecture, where an introduction will be given by one of Sweden’s best-known hepatitis C patients, Professor Hans Rosling. ... Full story

1 2 3 4 5 6 7 8 9 next total: 88 | displaying: 1 - 10